210 related articles for article (PubMed ID: 32398330)
1. A Call for Pediatric COVID-19 Clinical Trials.
Campbell JI; Ocwieja KE; Nakamura MM
Pediatrics; 2020 Aug; 146(2):. PubMed ID: 32398330
[No Abstract] [Full Text] [Related]
2. Audio Interview: Caring for Patients with Covid-19.
Rubin EJ; Baden LR; Morrissey S
N Engl J Med; 2020 Apr; 382(16):e50. PubMed ID: 32294372
[No Abstract] [Full Text] [Related]
3. Clinical Trial End Points in Severe COVID-19.
Desai A; Kulkarni A; Rajkumar SV; Gyawali B
Mayo Clin Proc; 2020 Aug; 95(8):1578-1580. PubMed ID: 32753131
[No Abstract] [Full Text] [Related]
4. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
Thalha AMM; Lee YY; Besari A; Omar SFS
J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
[No Abstract] [Full Text] [Related]
5. Targeting SARS-CoV-2 using polycomb inhibitors as antiviral agents.
Ayaz S; Crea F
Epigenomics; 2020 May; 12(10):811-812. PubMed ID: 32495654
[No Abstract] [Full Text] [Related]
6. A role for retinoids in the treatment of COVID-19?
Trasino SE
Clin Exp Pharmacol Physiol; 2020 Oct; 47(10):1765-1767. PubMed ID: 32459003
[TBL] [Abstract][Full Text] [Related]
7. COVID-19: Stay Cool toward Corticosteroids.
Fujishima S
Keio J Med; 2020 Jun; 69(2):27-29. PubMed ID: 32475851
[No Abstract] [Full Text] [Related]
8. COVID-19: Small-Molecule Clinical Trials Landscape.
Ferreira LLG; Andricopulo AD
Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
[No Abstract] [Full Text] [Related]
9. COVID-19 outbreak: the gold rush and the responsibilities of the scientific community.
Pezzani MD
Clin Microbiol Infect; 2020 Sep; 26(9):1123-1124. PubMed ID: 32422407
[No Abstract] [Full Text] [Related]
10. Chloroquine and COVID-19, where do we stand?
Lecuit M
Med Mal Infect; 2020 May; 50(3):229-230. PubMed ID: 32217166
[No Abstract] [Full Text] [Related]
11. Structural Biology Aids the Research of New Anti-COVID-19 Drugs.
Lu J; Liu X
Curr Org Synth; 2020; 17(3):162-163. PubMed ID: 32538717
[No Abstract] [Full Text] [Related]
12. Type 1 interferons as a potential treatment against COVID-19.
Sallard E; Lescure FX; Yazdanpanah Y; Mentre F; Peiffer-Smadja N
Antiviral Res; 2020 Jun; 178():104791. PubMed ID: 32275914
[TBL] [Abstract][Full Text] [Related]
13. Drug Repurposing Study Pinpoints Potential COVID-19 Antivirals.
Abbasi J
JAMA; 2020 Sep; 324(10):928. PubMed ID: 32897326
[No Abstract] [Full Text] [Related]
14. The Moral Imperative to Include Pregnant Women in Clinical Trials of Interventions for COVID-19.
Malhamé I; D'Souza R; Cheng MP
Ann Intern Med; 2020 Nov; 173(10):836-837. PubMed ID: 32598164
[TBL] [Abstract][Full Text] [Related]
15. The Landscape of Prescription Drug Shortages During the COVID-19 Pandemic.
Fox ER; Stolbach AI; Mazer-Amirshahi M
J Med Toxicol; 2020 Jul; 16(3):311-313. PubMed ID: 32458230
[No Abstract] [Full Text] [Related]
16. [Not Available].
Nau JY
Rev Med Suisse; 2020 Mar; 16(685):510-511. PubMed ID: 32167254
[No Abstract] [Full Text] [Related]
17. Potential therapeutic options for coronavirus disease 2019: using knowledge of past outbreaks to guide future treatment.
Lin J; Ouyang J; Peng XR; Isnard S; Fombuena B; Routy JP; Chen YK
Chin Med J (Engl); 2020 Jun; 133(11):1350-1352. PubMed ID: 32209887
[No Abstract] [Full Text] [Related]
18. [SARS-CoV-2 protease: an excellent target to develop drugs against COVID-19].
Ladoux A; Azoulay S; Dani C
Med Sci (Paris); 2020; 36(6-7):555-558. PubMed ID: 32558640
[No Abstract] [Full Text] [Related]
19. Lithium for the 2019 novel coronavirus.
Gómez-Bernal G
Med Hypotheses; 2020 Sep; 142():109822. PubMed ID: 32408073
[No Abstract] [Full Text] [Related]
20. [Not Available].
Fumeaux T
Rev Med Suisse; 2020 Jun; 16(697):1220. PubMed ID: 32520466
[No Abstract] [Full Text] [Related]
[Next] [New Search]
